The global aquaculture healthcare market size accounted for US$ 1.25 billion in 2023 and is projected to reach around USD 2.83 billion by 2033, growing at a CAGR of 8.54% from 2024 to 2033.
Key Points
- Asia-Pacific is likely to witness the fastest growth in the aquaculture healthcare market over the forecast period.
- By product, in 2023, the drugs segment dominated the market.
- By product, the medicated feed additives segment is expected to show significant growth over the forecast period.
- By species, the fish segment held the largest market share in 2023.
- By infection, the bacterial infection segment dominated the market in 2023.
- By route of administration, the topical segment dominated the market in 2023.
- By distribution channel, the retail aqua stores segment dominated the aquaculture healthcare market in 2023.
Report Summary
The global aquaculture healthcare market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the aquaculture healthcare market across the globe.
A comprehensive estimate on the aquaculture healthcare market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of aquaculture healthcare during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3919
Aquaculture Healthcare Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 8.54% |
| Global Market Size in 2023 | USD 1.25 Billion |
| Global Market Size by 2033 | USD 2.83 Billion |
| Largest Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Species, By Infection, By Route of Administration, and By Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized aquaculture healthcare market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Blood Gas and Electrolyte Analyzers Market Size Report By 2033
Market Players
The report includes the profiles of key aquaculture healthcare market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In May 2023, the Agriculture Insurance Company of India (AIC) is set to introduce insurance products for the livestock, aquaculture, and sericulture sectors. The company has already obtained the necessary license from India’s Insurance Regulatory and Development Authority (IRDAI).
- In November 2022, Indian Immunologicals Ltd. (IIL), based in Hyderabad, collaborated with the Central Institute of Fisheries Education (CIFE) to develop India’s first fish vaccine commercially.
Aquaculture Healthcare Market Companies
- Xylem Inc.
- Archer Daniels Midland Company
- Elanco
- Bayer Animal Health
- Merck & Co. Inc.
- Virbac S.A.
- Alltech
- Zoetis (Pfizer, Inc.)
- Benchmark Holdings Plc.
- Pentair plc.
- AKVA Group.
Segments Covered in the Report
By Product
- Vaccines
- Antibiotics
- Antifungals
- Parasiticides
- Anti-Viral Drugs
- Medicates Feed Additives
- Others
By Species
- Fishes
- Freshwater
- Tilapia
- Carp
- Others
- Marine Species
- Seabass Seabream
- Turbot
- Others
- Diadromous Species
- Salmon
- Trout
- Others
- Freshwater
- Crustaceans
- Prawns
- Shrimps
- Others
- Others
By Infection
- Bacterial Infection
- Viral Infection
- Parasitic Infection
- Fungal Infection
By Route of Administration
- Topical
- Oral
- Parenteral
- Immersion
- Spray
By Distribution Channel
- Veterinary Hospitals
- Veterinary Pharmacies
- Online Pharmacies
- Retail /Aqua Stores
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Aquaculture Healthcare Market
5.1. COVID-19 Landscape: Aquaculture Healthcare Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Aquaculture Healthcare Market, By Product
8.1. Aquaculture Healthcare Market, by Product, 2024-2033
8.1.1. Vaccines
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Antibiotics
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Antifungals
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Parasiticides
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Anti-Viral Drugs
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Medicates Feed Additives
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Aquaculture Healthcare Market, By Species
9.1. Aquaculture Healthcare Market, by Species, 2024-2033
9.1.1. Fishes
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Crustaceans
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Crustaceans
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Aquaculture Healthcare Market, By Infection
10.1. Aquaculture Healthcare Market, by Infection, 2024-2033
10.1.1. Bacterial Infection
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Viral Infection
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Parasitic Infection
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Fungal Infection
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Aquaculture Healthcare Market, By Route of Administration
11.1. Aquaculture Healthcare Market, by Route of Administration, 2024-2033
11.1.1. Topical
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Oral
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Parenteral
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Immersion
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Spray
11.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Aquaculture Healthcare Market, By Distribution Channel
12.1. Aquaculture Healthcare Market, by Distribution Channel, 2024-2033
12.1.1. Introduction
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. IDM
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Foundries
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. OSAT
12.1.4.1. Market Revenue and Forecast (2021-2033)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Aquaculture Healthcare Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Forecast, by Species (2021-2033)
13.1.3. Market Revenue and Forecast, by Infection (2021-2033)
13.1.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.1.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Species (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Infection (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.1.6.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Forecast, by Species (2021-2033)
13.1.7.3. Market Revenue and Forecast, by Infection (2021-2033)
13.1.7.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.1.7.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Forecast, by Species (2021-2033)
13.2.3. Market Revenue and Forecast, by Infection (2021-2033)
13.2.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.2.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Species (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Infection (2021-2033)
13.2.7. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.2.8. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Species (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Infection (2021-2033)
13.2.10. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.2.11. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Species (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Infection (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.2.13. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Species (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Infection (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.2.15. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Forecast, by Species (2021-2033)
13.3.3. Market Revenue and Forecast, by Infection (2021-2033)
13.3.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.3.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Species (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Infection (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.3.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Species (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Infection (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.3.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Species (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Infection (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Species (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Infection (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Forecast, by Species (2021-2033)
13.4.3. Market Revenue and Forecast, by Infection (2021-2033)
13.4.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.4.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Species (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Infection (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.4.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Species (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Infection (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.4.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Species (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Infection (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Species (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Infection (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Forecast, by Species (2021-2033)
13.5.3. Market Revenue and Forecast, by Infection (2021-2033)
13.5.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.5.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Species (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Infection (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.5.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Species (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Infection (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Route of Administration (2021-2033)
13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)
Chapter 14. Company Profiles
14.1. Xylem Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Archer Daniels Midland Company
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Elanco
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bayer Animal Health
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Merck & Co. Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Virbac S.A.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Alltech
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Zoetis (Pfizer, Inc.)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Benchmark Holdings Plc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pentair plc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
